Assessing the impact of gender and age differences on overall survival of patients with colorectal cancer
https://doi.org/10.17650/2949-5857-2024-14-2-11-16
Abstract
Introduction. Recent studies have led to the conclusion that gender is an important factor influencing the prognosis of survival of patients with colorectal cancer.
Aim. To analyze 5-year overall survival rates in patients with colorectal cancer of different sexes and in different age groups.
Materials and methods. The study included 1593 patients, of whom 720 were men (45.2 %) and 873 women (54.8 %). Patients were divided into 3 age groups: under 50 years, 50–70 years and over 70. Overall survival rates were calculated, followed by comparison between groups of patients, taking into account gender and stage of the disease.
Results. Analysis of treatment results taking into account a gender approach showed that the prognosis of the disease was most favorable in women. With approximately the same 5-year survival rate in men and women (54.9 and 52.7 %), this indicator correlated with the age of the patients and was significantly better than in men in the group of patients under 50 years of age.
Conclusion. The identified gender and age characteristics in the development and course of colorectal cancer are relevant for oncologists when choosing diagnostic, treatment and rehabilitation strategies.
About the Authors
B. I. Gataullin
Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University; Kazan State Medical Academy – branch of Russian Medical Academy of Continuing Professional Education, Ministry of Health
of Russia
Russian Federation
Russian Federation
74 K. Marks St., Kazan 420012; 36 Butlerova St., Kazan 420012
I. G. Gataullin
Kazan State Medical Academy – branch of Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia
Russian Federation
Russian Federation
36 Butlerova St., Kazan 420012
R. G. Biktemirova
Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University
Russian Federation
Russian Federation
74 K. Marks St., Kazan 420012
Ya. A. Erpert
Kazan State Medical Academy – branch of Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia
Russian Federation
Russian Federation
36 Butlerova St., Kazan 420012
N. F. Didakunan
Kazan State Medical University of Ministry of Health of Russia
Russian Federation
Russian Federation
49 Butlerova St., Kazan 420012
References
1. Sung H., Ferlay J., Siegel R.L. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71(3):209–49. DOI: 10.3322/caac.21660
2. Available at: http://www.socpolitika.ru/rus/ conferences/3985/3989/index.shtml
3. Kim S.E., Paik H.Y., Yoon H. et al. Sex- and gender-specific disparities in colorectal cancer risk. World J Gastroenterol 2015;21(17):5167–75. DOI: 10.3748/wjg.v21.i17.5167
4. Limsu D., Vierkant R.A., Tillmans L.S. et al. Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older women. Gut 2012;61(9):1299–305. DOI: 10.1136/gutjnl-2011-300719
5. Losurdo P., Mastronardi M., de Manzini N., Bortul M. Survival and long-term surgical outcomes after colorectal surgery: are there any gender-related differences? Updates Surg 2022;74(4):1337–43. DOI: 10.1007/s13304-022-01323-4
6. Majek O., Gondos A., Jansen L. et al. Sex differences in colorectal cancer survival: population-based analysis of 164,996 colorectal cancer patients in Germany. PLoS One 2013;8(7):e68077. DOI: 10.1371/journal.pone.0068077
7. Rutegard M., Shore R., Lu Y. et al. Sex differences in the incidence of gastrointestinal adenocarcinoma in Sweden 1970–2006. Eur J Cancer 2010;46(6):1093–100. DOI: 10.1016/j.ejca.2010.01.029
8. Gataullin B.I., Khasanov R.Sh., Savelyev A.A., Gataullin I.G. Gender specificity of colorectal cancer in the Republic of Tatarstan. Sibirskij onkologicheskij zhurnal = Siberian Journal of Oncology 2021;20(1):16–23. DOI: https://doi.org/10.21294/1814-4861-2021-20-1-16-23
9. Eli M., Mollayup A., Muattar J. et al. K-ras genetic mutation and influencing factor analysis for Han and Uygur nationality colorectal cancer patients. Int J Clin Exp Med 2015;8(6):10168–77. eCollection 2015. PMID: 26309716
10. Ferlay J., Soerjomataram I., Dikshit R. et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359–86. DOI: 10.1002/ijc.29210
11. Barzi A., Lenz A.M., Labonte M.J., Lenz H.J. Molecular pathways: estrogen pathway in colorectal cancer. Clin Cancer Res 2013;19:5842–8. DOI: 10.1158/1078-0432.CCR-13-0325
12. Maingi J.W., Tang S., Liu S. et al. Targeting estrogen receptors in colorectal cancer. Mol Biol Rep 2020;47(5):4087–91. DOI: 10.1007/s11033-020-05414-6
13. Conti L., Cornò M.D., Gessani S. Revisiting the impact of lifestyle on colorectal cancer risk in a gender perspective. Crit Rev Oncol Hematol 2020;145:102834. DOI: 10.1016/j.critrevonc.2019.102834
Review
Views:
289
Email this article 